Latest Breaking News On - Jonathans serody - Page 1 : comparemela.com

 E-Mail IMAGE: A diagram showing the various strategies that could enhance the activity of CAR T cells against breast cancer. view more  Credit: © 2020 Xu et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20200844 Activating an immune signaling pathway best known for fighting viral and bacterial infections can boost the ability of genetically engineered T cells to eradicate breast cancer in mice, according to a new study by researchers at the University of North Carolina. The study, to be published December 31 in the JEM), suggests that CAR T cells, which are already used to treat certain blood cancers in humans, may also be successful against solid tumors if combined with other immunotherapeutic approaches.

Jonathans serodyRockefeller universityUniversity of north carolina school medicineUniversity of north carolinaCellular therapy programExperimental medicineElizabeth thomas professorNorth carolina schoolராக்ஃபெல்லர் பல்கலைக்கழகம்பல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினா பள்ளி மருந்துபல்கலைக்கழகம் ஆஃப் வடக்கு கரோலினாசெல்லுலார் சிகிச்சை ப்ரோக்ர்யாம்சோதனை மருந்துஎலிசபெத் தாமஸ் ப்ரொஃபெஸர்வடக்கு கரோலினா பள்ளி